Skip to search formSkip to main contentSkip to account menu

Benserazide / Levodopa

Known as: benserazide, levodopa drug combination, benserazide - levodopa, co-beneldopa 
National Institutes of Health

Related topics

Related topics

6 relations
BenserazideLevodopa

Broader (3)

Dopaminergic AgentsDrug CombinationsEnzyme Inhibitors

Narrower (1)

Madopar

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Clinical and pharmacokinetics equivalence of multiple doses of levodopa benserazide generic formulation vs the originator (Madopar)
While several generic preparations of levodopa/carbidopa and levodopa/benserazide (LBD) are currently available, pharmacokinetic… 
2018
2018
Novel SERAC1 mutations in a Chinese patient presenting with parkinsonism and dystonia
A 22-year-old man was admitted to our hospital complaining of bradykinesia of the limbs, abnormal posture of neck and feet, and… 
2004
2004
Clinical efficacy of selegiline combined with benserazide-levodopa in treating Parkinson disease
1977
1977
Influence of the decarboxylase inhibitor benserazide on the antihypertensive effect and metabolism of alpha-methyldopa in patients with essential hypertension
SummaryIn a single-blind study, the dopa-decarboxylase inhibitor benserazide (375 mg/day for 3 days and 750 mg/day for further 3… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)